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Abstract
Aims: The Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium was
established by the National Institutes of Health in 2015 to expand research, practice, and policies
beyond the detection and treatment of lower urinary tract symptoms (LUTS) to the promotion and
preservation of bladder health and prevention of LUTS in girls and women. While many multidisciplinary scientific networks focus on pelvic floor dysfunction and LUTS, the PLUS
Consortium stands alone in its focus on prevention. This article describes the PLUS approach to
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developing a conceptual framework to guide the Consortium’s initial prevention research agenda.
Methods: The conceptual framework was informed by traditional social ecological models of
public health, biopsychosocial models of health, Glass and McAtee’s Society-Behavior-Biology
Nexus, and the World Health Organization’s conceptual framework for action on the social
determinants of health. Results: The PLUS conceptual framework provides a foundation for
developing prevention interventions that have the greatest likelihood of promoting and preserving
bladder health among diverse populations. Conclusions: PLUS Consortium work is premised on
the notion that programs, practices, and policies designed to promote health will have optimal
impact if the conceptual foundation upon which efforts are based is comprehensive and informed
by multiple disciplines. The PLUS conceptual framework is broadly applicable to domains of
health that have historically focused on the treatment of illness and symptoms rather than the
promotion of health. It is also applicable to domains of health that have been examined from a
predominantly biological or social ecological perspective, without integration of both perspectives.
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lower urinary tract symptoms; bladder health; girls; women; prevention; conceptual framework;
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Introduction
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The promotion of health and prevention of disease are essential components of public health.
1 In many domains of health, however, research and practice are focused primarily on the
identification and treatment of disease rather than the promotion of public health. The lower
urinary tract is one such domain. Lower urinary tract symptoms (LUTS) encompass a
variety of bothersome storage and emptying symptoms, including urgency urinary
incontinence (i.e., strong urge “to go” and losing urine before reaching a toilet), stress
urinary incontinence (e.g., losing urine with physical activity or increases in abdominal
pressure such as a cough or sneeze), frequent and/or urgent urination, nocturnal enuresis
(i.e., bed-wetting), difficulty urinating, dribbling after urination, and bladder or urethral pain
before, during, or after urination.2,3 LUTS are extremely common, with more than 200
million people worldwide and over 15% of women aged 40 years or older suffering from
urinary incontinence.4,5 Overactive bladder (OAB), a subset of LUTS, is characterized by
urinary urgency, with or without urgency incontinence, and usually with frequent daytime
and nighttime urination.3 In the United States (U.S.) and Europe, prevalence of OAB in
adults has been estimated at approximately 16%.6,7 Substantial public and private
investments have been made to diagnose and treat conditions associated with LUTS. For
example, there are currently over 20 medications for management of OAB; historically, there
have been over 200 different surgical procedures for stress urinary incontinence.8,9 The total
U.S. economic burden, including lost work productivity, of OAB with urgency urinary
incontinence was estimated to be $65.9 billion in 2007, with a projected annual estimate of
$82.6 billion by 2020.10
Prevention of LUTS is particularly important for girls and women. Women are 2–3 times
more likely to experience urinary incontinence and 4 times more likely to experience a
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urinary tract infection in comparison to men.11–14 In a large, population-based sample of
individuals from the United States, United Kingdom, and Sweden, 71% of men and 75% of
women reported at least one LUTS.15 Women are at higher risk for specific LUTS than men
due to the anatomy and physiology of the female urogenital system.16 Women’s hormonal
milieu, experiences during pregnancy and childbirth, and gendered societal experiences are
additional contributors.16,17 For example, women may encounter greater barriers to toileting
in public spaces (accessibility, privacy, safety, and cleanliness).17 While men report more
problems than women with bladder emptying, women report more problems with storage
and overall LUTS.18 Moreover, LUTS tend to begin earlier in the life course for women than
for men.7,16

Author Manuscript

The prevalence and incidence of LUTS among women varies across the life course.
Estimates of urinary incontinence in women range from 10% to 50%, depending on the
definition of incontinence and age of the population being studied.16,19 Generally, LUTS in
girls include urinary tract infections and nocturnal enuresis.20,21 In contrast, LUTS in
women predominantly include stress urinary incontinence during the reproductive years;
urgency and mixed urinary incontinence with increasing age;4 and urinary tract infections
after menopause.22 Early prevention of LUTS is important to public health promotion, as the
early experience of LUTS may predispose girls and women to reoccurrence, worsening, or
new onset of LUTS with age.22,23 Prevention of LUTS is important to the promotion of both
physical health and emotional well-being. Anxiety or depression is reported by more than
50% of women with LUTS, and social isolation is common.24,25 Thus, LUTS have
substantial impact on the health and quality of life of girls and women across the life course
and are important to prevent at all ages.

Author Manuscript

Challenging the Status Quo

Author Manuscript

Traditionally, LUTS have been viewed by western health care providers from a medical
model perspective that promotes a reactive response. In this model, girls or women develop
symptoms, seek help, and receive treatment that may or may not lead to cure or amelioration
of symptoms. Despite the medical model perspective, LUTS have been largely
underdiagnosed and undertreated, with up to 75% of women with urinary incontinence not
seeking care.26 This may be attributed to a sense of embarrassment or stigma that hinders
health care seeking and open communication, or to lack of knowledge on the part of affected
women or providers, including the misperception that LUTS are a normal part of being
female or aging.27–29 Over the past several decades, there has been a proliferation of
advertising campaigns for products designed to help women manage LUTS through
pharmaceuticals and incontinence aids.30,31 While advertisements for LUTS products may
help to reduce stigma,32 they may also serve to normalize the experience of LUTS. Women
may approach their providers for medication to treat LUTS, or they may be misled to think
their symptoms can only be managed by incontinence containment products. Thus, both the
medical model and profit-incentivized industries 33 have contributed to societal norms
focused on the treatment and self-management of LUTS rather than prevention.
Additionally, financial incentives for health care systems and providers have been linked to
the identification and treatment of disease, rather than the promotion of health and

Neurourol Urodyn. Author manuscript; available in PMC 2019 November 01.

Brady et al.

Page 5

Author Manuscript

prevention of disease.34 While investment in the prevention of other prevalent conditions
such as obesity,35 cardiovascular disease,36 colorectal cancer,37 and infectious diseases 38
has increased, investment in the prevention of LUTS has lagged. A small body of literature
has identified potentially modifiable risk factors for LUTS and examined the impact of
prevention strategies;39–42 this literature has begun to expand the focus of research and
practice towards the prevention of LUTS among girls and women. However, to shift the
prevailing health care paradigm to an emphasis on prevention, coordinated efforts on the part
of scientists and health care professionals are needed.

Materials and Methods

Author Manuscript
Author Manuscript

The Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium was
established in 2015 to expand research, practice, and policies beyond the detection and
treatment of LUTS to the promotion and preservation of bladder health and prevention of
LUTS in girls and women.43 While many multidisciplinary research networks focus on
pelvic floor dysfunction and LUTS, the PLUS Consortium stands alone in its focus on
prevention. The PLUS Consortium is comprised of a transdisciplinary network of
professionals, including community advocates, health care professionals, and scientists
specializing in pediatrics, adolescent medicine, gerontology and geriatrics, nursing,
midwifery, behavioral medicine, preventive medicine, psychiatry, neuroendocrinology,
reproductive medicine, female pelvic medicine and reconstructive surgery, urology,
infectious diseases, clinical and social epidemiology, prevention science, medical sociology,
psychology, women’s studies, sexual and gender minority health, community-engaged
research, community health promotion, scale development, research methods, and
biostatistics. Early conversations between network members acknowledged the diversity of
girls and women with respect to sexual orientation and gender identity (SOGI). Members
agreed to include SOGI measures in PLUS studies and to develop inclusion/exclusion
criteria for cisgender and transgender individuals that fit the scientific objectives of each
study.
To shift research, practice, and policies to a focus on health, the PLUS Consortium identified
two initial tasks that it pursued in parallel. First, the Consortium drafted a definition of
bladder health.44 Consistent with the World Health Organization’s definition of health,45 the
PLUS Consortium conceptualizes bladder health as “a complete state of physical, mental

and social well-being related to bladder function, and not merely the absence of LUTS,”
with function that “permits daily activities, adapts to short term physical or environmental

Author Manuscript

stressors, and allows optimal well-being (e.g., travel, exercise, social, occupational or other
activities).” Second, the Consortium adopted a prevention science paradigm and developed a
conceptual framework to guide the Consortium’s initial prevention research agenda. The
Consortium began this task by establishing a shared understanding of prevention science
among its diverse members. The Consortium then drew from separate, but complementary
theoretical traditions and contemporary writings to develop the PLUS conceptual
framework. The purpose of this manuscript is to describe the PLUS approach in developing
a conceptual framework to guide the Consortium’s initial prevention research agenda.
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Results
Adoption of a Prevention Science Paradigm

Author Manuscript

An underlying premise of prevention science is that one must understand what leads to
disease and how disease can be prevented in order to promote and preserve health.
Prevention science involves the systematic study of potential precursors to human
dysfunction and health, termed risk and protective factors, respectively.46,47 Risk factors are
those attributes, characteristics, or exposures of an individual that increase the likelihood of
developing a disease. In contrast, protective factors enhance health and lessen the likelihood
that dysfunction will occur in response to risk factors. Risk and protective factors at different
levels of social ecology have also been referred to as social determinants of health.48,49
Prevention scientists conduct etiologic studies to identify risk and protective factors across
different levels of biology and the social ecology that surrounds individuals.46,47 They also
develop and test prevention interventions aimed at modifying risk and protective factors,
with the goal of promoting health and preventing or moderating major dysfunction before
onset of disease or disorder. Prevention science applies a life course developmental
perspective to etiologic research and rigorous intervention methodology.50 Dissemination of
findings are expected to impact health promotion programs, practices, and policies, and in
turn, the health of populations across the life course.
Development of the PLUS Conceptual Framework

Author Manuscript

Developing a conceptual framework that encompasses all facets of social ecology, integrates
biology with social ecology, and emphasizes a life course perspective is key to the adoption
of a prevention science paradigm. The PLUS conceptual framework is informed by
traditional social ecological models of public health and biopsychosocial models of health. It
also integrates contemporary conceptualizations of public health that explicitly acknowledge
the role of societal structures in creating health inequities – namely, Glass and McAtee’s 51
Society-Behavior-Biology Nexus and the World Health Organization’s Conceptual
Framework for Action on Social Determinants of Health.52 In the sections below, each
model and framework that informed the PLUS conceptual framework is reviewed. These
resources may serve as valuable tools in effecting other paradigm shifts in health among
scientists, practitioners, and policymakers.

Author Manuscript

Social ecological conceptualizations of public health situate individuals within environments
of interrelated, interacting, and nested spheres of influence on health and health behavior.
Social ecological models traditionally draw from theories of individual behavior and
interpersonal relations, which may be thought of as proximal social influences, as well as
sociological structures such as institutions, communities, cultures, and policy landscapes,
which may be thought of as distal social influences.53 Social ecological models hail from the
work of behavioral scientists and systems theorists, including Brofenbrenner’s pioneering
conceptualization of systems at multiple levels of social ecology that influence child
development.54 A social ecological conceptualization allows public health scientists and
practitioners to consider individuals within an ecosystem of risk and protective factors
beginning with the intrapersonal level (genetics, psychology, health status) and extending
outward to the interpersonal (family, peer, partner influence), institutional (school, work,
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health care system), community (cultural norms), and societal (policies, laws, economics)
levels. By identifying prevention opportunities at multiple levels of influence, public health
professionals aim to effectively promote both individual and population health.

Author Manuscript

Social ecological models have increasingly been applied in health promotion and
intervention contexts over the past 40 years.55 A variety of factors have led to this trend,
including increased attention to social determinants of health and health inequities;
recognition of the limitations of focusing only on linear causality via proximal individuallevel risk factors; and frustration with individual behavior change interventions that do not
account for contextual influences.55–58 Social ecological approaches have been applied most
often in public health interventions to change behaviors such as nutrition intake, physical
activity, and smoking.59 For example, a behaviorally-focused ecologic approach to improve
nutrition and physical activity within a population might include education for individuals;
modifying home cooking practices for families; engaging schools and workplaces to support
access to fresh, healthy food options; fostering healthy norms and ensuring access to healthy
foods in the community; and taxing unhealthy foods and funding the creation of public
exercise spaces. Social ecological approaches have been utilized less often to understand
physiologic dysfunction, such as LUTS. Public health scientists and organizations
increasingly value multilevel approaches to public health promotion that address a broad
array of influences, from genes to macroeconomics.60–62

Author Manuscript
Author Manuscript

As behavioral scientists began to widen the lens of social ecology to explain health and
disease, physicians and other health care professionals began to integrate biology and social
context. Roughly 40 years ago, biopsychosocial (BPS) models of health were proposed as an
alternative to the prevailing biomedical model.63 Engel advocated a new multilevel systems
approach that would acknowledge not only the organic or biological basis of disease, but
also “the patient, the social context in which he lives, and the complementary system devised
by society to deal with the disruptive effects of illness.” Essentially holistic, the basic
assumption of the BPS model is that all illness is a complex reciprocal interaction of
biological, psychological, and social factors.64 The BPS model, similar to other social
ecological models, has been proposed as a framework for understanding conditions that are
determined by interrelated, interacting risk and protective factors, such as multimorbidity 65
and the obesity epidemic.66 Application of the BPS model is not without criticism, however.
For example, Henningsen 67 observed that attention to the “bio” component in the BPS
model has grown at the expense of “psychological” and “social” components, potentially
because biologically-based treatments are preferred by many medical practitioners and
confer greater economic advantage to institutions. Further, Henningsen noted that a focus on
“psychosocial” determinants of health proximal to the individual has resulted in missed
opportunities to focus on important “sociocultural” determinants of health that are distal to
the individual.67
Glass and McAtee’s Society-Behavior-Biology Nexus.—Over a decade ago,
Thomas Glass and Matthew McAtee 51 developed the Society-Behavior-Biology Nexus to
integrate social ecological and biological influences on health. Their model depicts nested
spheres of influences both within and outside of the individual, who moves through time
from infancy to old age. The Society-Behavior-Biology Nexus situates the individual within
Neurourol Urodyn. Author manuscript; available in PMC 2019 November 01.
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nested systems of social organization, ranging outward to encompass the micro-level
(family, social networks), mezzo-level (schools, worksites, communities, health care
systems), macro-level (states, nations), and global level (geopolitics, economic and
environmental dynamics). Unlike most social ecological models, the Society-BehaviorBiology Nexus explicitly highlights nested systems of biological organization within the
individual, ranging inward to encompass multi-organ systems, cellular level influences, subcellular/molecular level influences, and the genomic substrate.

Author Manuscript

The Society-Behavior-Biology Nexus integrates social ecology and biology through the
concepts of embodiment 68 and gene-by-environment interactions. Social ecological risk and
protective factors, which Glass and McAtee 51 framed as societal constraints and
opportunities, can become embodied with respect to biological function. Expression of
biologically-based predispositions towards health or disease can also be triggered by specific
social ecological contexts. Glass and McAtee 51 developed the concept of a risk regulator to
emphasize societally imposed constraints against and opportunities for health. Risk
regulators include material conditions; discriminatory practices, policies, and attitudes;
neighborhood and community conditions; behavioral norms, rules, and expectations;
conditions of work; and laws, policies, and regulations. Risk regulators can influence health
and disease through multiple, potentially complex pathways over time. For example,
different risk and protective factors might accumulate, influence one another, and influence
health outcomes in a bi-directional fashion. Identifying the initial cause of a health effect is
less important than knowing that a cluster of risk and protective factors appears to play a
causal role in the maintenance of health, or the generation or exacerbation of poor health.
For this reason, prevention programs must address societally imposed constraints on health
early in life and throughout the life course in order to be effective.

Author Manuscript
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The PLUS Consortium chose to adapt Glass and McAtee’s 51 model because it stimulates
thought about a broad spectrum of factors that may influence health across the life course.
Figure 1 depicts a condensed version of the PLUS conceptual framework to guide studies
investigating the etiology and prevention of LUTS and promotion of bladder health. This
framework shows how environmental risk and protective factors (e.g., constrained or
unconstrained toilet access) can become embodied in the structure and functioning of
biological systems that affect bladder health and the development of LUTS. The framework
also includes the potential for gene-by-environment interactions. Genetic and biological
predispositions towards bladder health and the development of LUTS may be more likely to
be expressed in specific social and environmental contexts. Throughout the life course,
individual behavior is a critical determinant of bladder health and LUTS. Whereas Glass and
McAtee 51 depicted behavior within an arrow representing the life course, the PLUS
Consortium depicts bladder health and LUTS within this arrow (see center of Figure 1).
Behavior is grouped with cognitive, affective, and psychosocial attributes of the individual.
Prevention strategies can target specific social ecological determinants of bladder health and
LUTS, as well as behaviors that can ameliorate genetic and biological vulnerabilities.
World Health Organization’s (WHO) Conceptual Framework for Action on
Social Determinants of Health.—Glass and McAtee’s 51 Society-Behavior-Biology
Nexus draws attention to the role of risk regulators in creating health inequities. However,
Neurourol Urodyn. Author manuscript; available in PMC 2019 November 01.
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the framework is not explicit about how risk regulators are created and maintained. The
World Health Organization (WHO) established a Commission on Social Determinants of
Health to summarize evidence for how the structure of societies – through governance,
policies, culture, and values – determines the health of populations.52 Namely, a society
stratifies its population according to income, education, occupation, gender, race, ethnicity,
and other factors. From these social stratifications, social hierarchies result. Position within
the social hierarchy in turn shapes specific social determinants of health. Thus, the WHO
framework separates structural determinants of health inequities, the distal factors rooted in
a society’s political, economic, and social structures (e.g., macroenonomic and public
policies), from social determinants of health, a more commonly understood term that refers
to proximal factors rooted in one’s social position (e.g., living and working conditions). The
WHO framework asserts that a society produces health and disease among its citizens. The
framework also asserts that policymakers bear responsibility for creating and maintaining
health equity among populations, as well as redressing the structural factors that produce
under-resourced communities and health inequities.

Author Manuscript

Inclusion of the WHO perspective within the PLUS conceptual framework has allowed the
Consortium to intentionally consider issues of health equity and social justice in its
development of a population-based prevention science agenda. Health disparities 69 are
defined as differences in health that are closely linked with economic, social, or
environmental disadvantage. Whereas a health disparity highlights no explicit cause for the
disparity, a health inequity highlights a difference in health that is imposed by society and is
unnecessary, avoidable, and unjust.70,71 The WHO framework highlights the importance of
policy-based interventions as part of a multi-level population-based prevention strategy.
Insufficient attention to policies that impact the conditions in which people live and their
opportunities to be healthy could inadvertently generate or widen health inequities over time
and across generations. This can occur even when the health of all communities is
improving. The WHO framework can enhance the impact of the PLUS Consortium by
encouraging prevention interventions at distal, structural levels (e.g., federal policies) rather
than solely focusing on individual and proximal levels of influence in the environment (e.g.,
the built environment). While prevention interventions that aim to influence social
determinants of health typically function at the community level, prevention interventions at
the structural level aim to change a society’s political, economic, and social systems – the
factors that give rise to disadvantageous social groupings and socioeconomic positions.
Applying the PLUS Conceptual Framework to Build a Prevention Research Agenda

Author Manuscript

Initial PLUS Consortium activities were designed to engage members in a series of analytic
processes to develop the PLUS conceptual framework and inform the Consortium’s initial
prevention research agenda. First, Consortium members identified levels of social ecology
and biology that are relevant to the PLUS Consortium. As shown in Table 1 (see columns),
Consortium members divided individual-level risk and protective factors into those that were
biological (biology/body) and those that were cognitive, affective, or behavioral (mind/
behavior). The Consortium separately considered interpersonal risk and protective factors
for LUTS and bladder health. Because of the Consortium’s life course perspective,
interpersonal factors include the influence of parents and other family members during early
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life (e.g., toileting techniques and habits), as well as peers and partners later in life.
Consistent with social ecological models of public health and Glass and McAtee’s 51 notion
of risk regulators, the Consortium focused on institutional factors that may influence LUTS
and bladder health (e.g., access to bathroom facilities within schools and workplaces;
cleanliness, privacy, and safety of facilities). Consistent with the WHO distinction between
social determinants of health and structural determinants of health inequities,52 the
Consortium focused on community and societal level factors that may influence LUTS and
bladder health (e.g., neighborhood safety and cohesion; public bathroom infrastructure and
access; policies and laws governing control over fluid intake and voiding opportunity in
schools and workplaces).

Author Manuscript

Once the Consortium had identified different levels of biology and social ecology that may
influence LUTS and bladder health, members focused on generating potential risk and
protective factors within each level of the framework. Potential factors were generated based
on existing literature, theories of health and human behavior, and clinical and professional
observation. The nested levels of influence within and outside of the individual served as
prompts to consider risk and protective factors that may have been outside of one’s area of
expertise. A conceptual framework encapsulates what is possible to study; thus, it is
intentionally comprehensive. The Consortium generated over 600 potential risk and
protective factors. While such an exercise and resulting product appeared overwhelming, this
activity was critical to building a prevention science research agenda. A systematic approach
to studying potential precursors to LUTS and bladder health ideally begins with a
comprehensive list of all that is possible to study.
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PLUS Consortium members next engaged in an activity to prioritize risk and protective
factors for study. By design, the interests of individual research members and teams within
the Consortium are broad. It is thus not surprising that from the original list of over 600
potential risk and protective factors, over 400 factors remained after initial prioritization (see
Supplemental Appendix). Prioritized risk and protective factors were clustered into 8 broad
research themes to facilitate the selection of factors for study. Table 1 organizes several of
the PLUS Consortium’s prioritized factors by research theme (see rows) and level of
ecology (see columns).
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The organization of risk and protective factors by research theme and level of ecology can
serve as a tool to generate study-specific conceptual models. Whereas a conceptual
framework encapsulates what is possible to study, a conceptual model encapsulates what a
research team has prioritized and chosen to study.72 A conceptual model shows the
mechanisms by which specific risk and protective factors may be linked with health
outcomes. Figure 2 depicts one example of a conceptual model that emerged through
discussion. In this example, girls who attend schools and women who work in occupational
settings where policies, norms, and practices prohibit timely access to bathrooms (i.e.,
autonomy) may restrict their fluid intake and hold urine until it is painful or urine leakage
occurs. Institutional policies, norms, and practices may also impact perceived privacy, safety,
and cleanliness of bathrooms, which in turn may lead to fluid restriction and delayed
voiding. In addition, perceived cleanliness of bathrooms may lead to adjustment of toileting
position (e.g., hovering versus sitting). Behavioral habits (e.g., fluid restriction, delayed
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voiding, hovering) may in turn increase the likelihood of adverse health outcomes (see
Figure 2).

Author Manuscript

In addition to identifying and organizing potential determinants of LUTS and bladder health
according to different levels of the ecological and biological systems depicted in Figure 1,
Consortium members delineated different life stages that are relevant to PLUS (see Table 2).
73–75 The PLUS Consortium acknowledges variation within a chronological age period and
views developmental status and events related to the lower urinary tract as more relevant to
bladder health than chronological age. Developmental stages are delineated by chronological
age to provide a rough index of who may be impacted by specific aspects of social ecology.
Table 2 shows how the social ecological context of a female individual may vary by life
stage. A comprehensive list of all contextual factors that vary by development is not shown.
Rather, Table 2 summarizes factors judged by the PLUS Consortium to be particularly
relevant to LUTS and bladder health. Table 2 illustrates the importance of studying girls and
women across the life course.

Discussion
As the PLUS Consortium evolves, its conceptual framework and supporting materials will
be modified as new terminology, concepts, and risk and protective factors for LUTS and
bladder health are identified. Thus, the Consortium intends to be open and agile in its ability
to respond to new developments in science and society.

Author Manuscript

The Consortium has begun to develop a prevention research agenda that is applying the
PLUS conceptual framework presented in this manuscript. The framework is not only of
value in selecting risk and protective factors that may influence LUTS and bladder health,
but also in selecting potential confounders – those variables that may influence both the
hypothesized predictor and outcome variable, resulting in a spurious (false) association.76
By identifying, measuring, and statistically adjusting for potential confounders in analyses, a
research team can better isolate the contribution of hypothesized risk and protective factors
to LUTS and bladder health. Confidence in results is enhanced when multiple studies – with
different samples, study designs, and analytic approaches – support the causal role of
hypothesized risk and protective factors.

Author Manuscript

The PLUS research agenda is expected to be implemented in a manner that corresponds to
phases of translational research. Fishbein and colleagues 77 recently refined and extended
the phases of basic science translational research for application to prevention science.
Current efforts of the Consortium correspond to the first phase, discovery science (T0),
which involves the identification of risk and protective factors to inform future prevention
efforts. Remaining phases of prevention science translational research 77 correspond to
future efforts of the PLUS Consortium, including methods and program development (T1),
efficacy and effectiveness trials (T2), and real world applications and dissemination (T3).
The time period necessary to demonstrate efficacy and effectiveness of prevention
interventions will likely depend on a number of considerations, including the risk or
protective factor being targeted (e.g., school or workplace policy governing access to toilets,
family- or peer-based toileting norms, individual toileting behaviors); the outcome being
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examined (e.g., continence, UTI); the population of girls or women being studied (e.g., those
who are asymptomatic vs. symptomatic, corresponding to primary vs. secondary
prevention); and the period of time during which the LUTS under study typically develop.
While it is difficult to anticipate the specific amount of time necessary to demonstrate
efficacy or effectiveness of a prevention intervention, allowing 6 months to a year would be
a reasonable initial approach. Degree of bladder health and LUTS should be examined, as
opposed to an outcome that does not facilitate the identification of promising trends. In
addition, it is important to examine whether the prevention intervention successfully altered
the targeted risk and protective factors.

Author Manuscript

It is anticipated that phases T0-T3 will be followed by scaling and policy reform (T4), which
involves wide-scale implementation, adoption, and institutionalization of new guidelines,
practices, and policies.77 The final phase of prevention science translational research is
globalization and public opinion (T5), which involves the cultivation of a fundamental and
universal change in social systems, including policies and norms that promote bladder
health.77 Phases T4 and T5 will allow the PLUS Consortium to impact social determinants
of health, and potentially, structural determinants of health inequities.52 In addition to policy
changes within organizations, legislation may be enacted to ensure that all members of a
diverse society are embedded within institutions and communities that promote health. This
approach is consistent with calls to ensure “potty parity” with respect to the planning and
design of public restrooms.78

Author Manuscript

While the PLUS conceptual framework and prevention science paradigm promotes rigorous
science, additional approaches are needed to ensure that the Consortium’s research is
informed by the lived experiences of girls and women and that resulting prevention
interventions are likely to be well-received. For this reason, the PLUS Consortium is
examining the extent to which community engagement principles can be incorporated into
initial and ongoing activities. Authentic engagement with community stakeholders allow
scientists and practitioners to mobilize resources, influence systems, and serve as catalysts
for changing programs, practices, and policies.79–81

Conclusions

Author Manuscript

The Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium was
established by the National Institutes of Health in 2015 to expand research, practice, and
policies beyond the detection and treatment of lower urinary tract symptoms (LUTS) to the
promotion and preservation of bladder health and prevention of LUTS. The PLUS
Consortium is tasked with significantly expanding the prevention science literature on LUTS
and promotion of bladder health. PLUS Consortium work is premised on the notion that
programs, practices, and policies designed to promote health will have optimal impact if the
conceptual foundation upon which efforts are based is comprehensive and informed by
multiple disciplines. The tables and figures of this manuscript are tools that can be used to
select, prioritize, and model risk and protective factors for study by all scientists interested in
bladder health. The PLUS conceptual framework provides a foundation for developing
prevention interventions that have the greatest likelihood of promoting and preserving
bladder health among diverse populations.
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While the Consortium’s work is focused on prevention of LUTS and promotion of bladder
health, the PLUS conceptual framework is broadly applicable to any domain of health that
has historically focused on the treatment of illness and symptoms rather than the promotion
of health. It is also broadly applicable to domains of health that have been examined from a
predominantly biological or social ecological perspective, without integration of both
perspectives. Work of the PLUS Consortium will contribute to the rich, evolving history and
practice of prevention science, as well as the conceptualization of public health.
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Figure 1.

Prevention of Lower Urinary tract Symptoms (PLUS) among girls and women: A conceptual
framework adapted from Glass and McAtee (2006).50
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Figure 2.

Sample conceptual model: Mechanisms by which schools and workplaces may influence
bladder health and LUTS among girls and women (adapted from PLUS conceptual
framework and Wang and Palmer, 2010).80
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bladder health, LUTS,
and delivery preference
(vaginal, Cesarean)

• Toilet training
experience
• Family and peer
toileting norms in
private and public
bathrooms
• Discussion with
family, peers, and
health care providers
about toileting habits
and techniques

Interpersonal

Level of Social Ecology

• Industry-institution
partnerships (e.g.,
school and workplace
contracts with beverage
companies)

• Policies and practices
regarding provision of
pelvic health education
within schools,
workplaces, health care
institutions
• Work requirements
(e.g., heavy lifting)

• Placement of
incontinence products
in stores
• Work requirements
(e.g., heavy lifting)
• Bladder health
competence of health
care providers

• Bladder health
competence of health
care providers
• Practice guidelines
regarding Cesarean
delivery

• Bathroom
infrastructure, privacy,
safety, and cleanliness
within organizations
(e.g., schools,
workplaces)
• Presence of familyfriendly/gender-neutral
bathrooms
• Formal policies and
informal practices
governing bathroom
access within
organizations

Institutional

• Social determinants of health
(e.g., neighborhood walkability,
access to fresh produce)
• Industry influences (e.g.,
marketing of beverages)

• Community-and societallybased messaging about pelvic
health

• Policies and laws governing
access to and quality of health
care
• Industry influences (e.g.,
promotion of incontinence
products, pharmaceuticals)

• Policies and laws governing
access to and quality of prenatal
and postnatal health care

• Public bathroom infrastructure,
privacy, safety, and cleanliness
• Policies and laws governing
bathroom access (e.g., “potty
parity”) and family-friendly/
gender-neutral bathrooms
• Industry influences (e.g.,
marketing of “Squatty Potty”)
• Myths (e.g., toilet seats spread
disease)

Community & Society

A sample of prioritized risk and protective factors for LUTS and bladder health among girls and women, by research theme and level of social ecology.

Author Manuscript
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• Microbiome
• Host response
• Infections
• Inflammation

• Puberty
• Menopause
• Local vaginal hormones
• Systemic hormones

Infections and Microbiome

Hormonal Status Across the
Lifespan

• Production of stress hormones

b

• Contraceptive use
• Hormone replacement therapy

• Genital / pelvic hygiene
• Sexual behavior
• Time to post-coital micturition

• Mental health conditions impacting
executive control
• Anxiety or phobias about public
toilets

Individual (Mind/Behavior)

of hormones

b

hormones
• Patient-provider
discussions about use

b

• Family and peer
norms about use of

• Family, peer, and
partner norms about
hygiene and sexual
behavior
• Patient-provider
discussions about
hygiene and sexual
behavior

• Traumatic events
(e.g., sexual abuse)
• Chronic stressors

Interpersonal

b

• Practice guidelines
and uptake for
prescription of
hormones by providers

• Policies and practices
regarding provision of
genital / pelvic hygiene
and sexual health
education within
schools and health care
institutions

• School and workplace
safety
• Workplace autonomy

Institutional

• Policies and laws governing
access to and quality of health
care

• Policies and laws governing
access to and quality of health
care

• Social determinants of health
(e.g., safety, social cohesion)

Community & Society

Listed risk and protective factors in 3 of the 40 cells of Table 1 were not prioritized for study by the PLUS Consortium; information is included in these cells to illustrate how a research theme may be
studied across all levels of biology and social ecology.

b

The body of the table shows sample risk and protective factors that have been prioritized for study by the PLUS Consortium. See the Supplemental Appendix for a complete list of prioritized risk and
protective factors.

a

Author Manuscript

Biopsychosocial Ecology of
Stress and Brain Health

Author Manuscript
Individual (Biology/Body)

Author Manuscript

Research Theme

Author Manuscript

Level of Social Ecology
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Author Manuscript

Author Manuscript

Author Manuscript
• Puberty and rapid physical
growth; potential scoliosis
• Pelvic anatomy changes
• Onset of menarche; development
of adult breast and reproductive
organs
• Pregnancy, childbirth, and related
musculoskeletal changes/injury
• Age-related sarcopenia

• Osteoarthritis and other causes of
knee, hip, and low back pain
• Menopause
• Estrogen withdrawal
• Post-menopausal changes
• Decreased Estrogen Levels
• Frailty

Early, 11–14
Later, 15–17

Emerging, 18–25
Young, 26–34
Adulthood, 35–44
Midlife, 45–54
Later, 55–64
Youngest, 65–74
Middle, 75–84
Oldest, 85+

Adolescence

Emerging &
Young Adulthood

Adulthood

Older Adulthood

• Increased prevalence of cognitive
impairment
• Polypharmacy

• Exogenous hormone therapy

• Assisted reproductive
technologies

• Building skills for selfsufficiency and increased
autonomy
• Birth control/ hormone
manipulation
• Influence of high impact sports
on musculoskeletal function, pelvic
floor

• Refinement of perceptual and
motor skills
• Development of personal
competencies
• Increase in logical reasoning

• Cognitive development
• Stool withholding

Individual (Mind/Behavior)

• Support for/
reaction to retirement
• Transition of family
to role of caregivers

• Transitions in
caregiving

• Responsibility for
dependents (children/
aging parents)

• Development of
relationships with
adults outside the
family (potential
sources of influence
on behavior)
• Onset of sexual
activity

• Parental/ extended
family influences on
toileting and hygiene
• Peer influence
begins

• Toilet Training

Interpersonal

a

• Long-term care
policies and
requirements for
toileting, assistance
provided

• Potential
increases in
workplace
responsibilities

• Workplace
influences on
toileting

• Independent
exposure to
institutional
settings (e.g.,
school clinics;
sexual health
clinics; first job/
workplace)

• School influences
on toileting

• Daycare and
preschool policies
and requirements
for toilet training

Institutional

Contextual factors are placed within the stage of the life course when they typically begin to be observed. Factors may still apply during a later life stage.

a

• Musculoskeletal impact of
bladder/ bowel withholding
maneuvers or straining

• Physical development
• Constipation
• Neuro-developmental conditions

5–10

<5

Individual (Biology/Body)

Later Childhood

Early Childhood

Age in Years

Examples of contextual factors that are particularly relevant to bladder health among girls and women, by life course stage.

• Ageism

• Receptivity to industry
messages about incontinence
and other LUTS

• Potentially uncertain access
to health care due to
insurance policies/laws

• Greater susceptibility to
cultural norms and taboos
that shape toileting, hygiene,
sexual behavior, fluid intake,
diet, and other lifestyle
behaviors

• Exposure to social
influences more broadly than
family and peers

• Social norms regarding
timing and techniques of
toilet training

Community & Society

Author Manuscript

Table 2.
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